IDiyas

For the Inventor, By the Inventor

Carlsbad, CA, United States of America

Dimitri Emil Grigoriadis

USPTO Granted Patents = 7 


Average Co-Inventor Count = 1.9

ph-index = 3

Forward Citations = 108(Granted Patents)


Location History:

  • Carlsbad, CA (US) (1998 - 2006)
  • San Diego, CA (US) (2021 - 2023)

Company Filing History:

goldMedal6 out of 120 
 
Neurocrine Biosciences, Inc.
 patents
silverMedal1 out of 106 
 
Dupont Pharmaceuticals Company
 patents

Years Active: 1998-2023

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents
1. 11730739 - Treatment of congenital adrenal hyperplasia (2023-08-22),
2. 11311544 - Treatment of congenital adrenal hyperplasia (2022-04-26),
3. 10905690 - Treatment of congenital adrenal hyperplasia (2021-02-02),
4. 7034118 - [object Object] (2006-04-25),
5. 6723841 - Corticotropin-releasing factor2 receptors (2004-04-20),
6. 6342503 - 1N-alkyl-n-arylpyrimidinamines and derivatives thereof (2002-01-29),
7. 5786203 - Isolated nucleic acid encoding corticotropin-releasing factor.sub.2 (1998-07-28),
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…